Epilepsy Therapeutics Market - Global Industry Analysis

Epilepsy Therapeutics Market By Drugs (First Generation Anti-epileptics, Second Generation Anti-epileptics, Third Generation Anti-epileptics), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Others), By Location (Rural and Urban), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028

Published Date: 11-May-2022 Category: Pharmaceutical Report Format : PDF Pages: 172 Report Code: ZMR-91 Status : Published

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

Industry Prospective:

The global Epilepsy Therapeutics market was worth around USD 13 billion in 2021 and is estimated to grow to about USD 18.1 billion by 2028, with a compound annual growth rate (CAGR) of approximately 3.5 percent over the forecast period The report analyzes the Epilepsy Therapeutics market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Epilepsy Therapeutics market.

Epilepsy Therapeutics Market: Overview

Epilepsy Therapeutics refers to chronic neurological disorder which causes constant and unfounded seizures. An individual suffering from Epilepsy Therapeutics tends to have seizures with no explanation. In Epilepsy Therapeutics, the brain activity becomes abnormal, resulting in recurrent seizures that are short episodes of involuntary movement, which may involve a part of the body or the entire body. The increase in the number of accidents and brain injuries and the high rate of post-traumatic Epilepsy Therapeutics (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries are the major factors driving the Epilepsy Therapeutics treatment market.

Furthermore, innovation of new treatment products with better efficiency is expected to further drive this market. Rising number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that have been observed in the global Epilepsy Therapeutics market. Besides development of new drugs and treatment options, approval and launch of new products extend profitable opportunities to the Epilepsy Therapeutics treatment market players in the forecast period.

In Addition, development of highly efficacious products, having less side-effects, and better outcomes are likely to propel the Epilepsy Therapeutics market Neurological disorders have become a matter of concern for medical researchers who are looking at optimizing medical treatments. Furthermore, the adoption of anti-epileptics due to increasing seizures and Epilepsy Therapeutics cases, and a rise in research and development is driving the growth of Epilepsy Therapeutics market. .However, factors such as lack of awareness about the condition some developing regions and reluctance to adopt Epilepsy Therapeutics medications in some regions are restraining the growth of the Epilepsy Therapeutics market over the upcoming years.

COVID-19 Impact:

The new coronavirus has spread worldwide in a relatively short period and has become a pandemic. Many affected patients have symptoms such as dry cough, tiredness, dyspnea, and fever. However, the infection with Covid-19 disrupts multiple tissues, including the kidney, liver, and nervous system. Common neurological symptoms of Covid-19 infection include delirium, depression, fever, and loss of smell and taste. It can cause stroke and epilepsy in rare cases. Furthermore, due to concerns about patient-to-patient transmission, standby admissions in hospitals with COVID-19 inpatients or in areas with widespread COVID-19 infection have been severely limited.

According to an article published in March 2020 titled "Epilepsy and COVID-19: Updated Evidence and Narrative Review," a survey of 212 pediatric neurologists from 49 countries found that in-person outpatient visits have decreased, and telemedicine use has increased during the pandemic. This has risen the demand for efficient epilepsy cures and medications.

Moreover, the growing R&D investments towards COVID 19 treatments may also contribute towards the epilepsy market growth.

Global Epilepsy Market

Epilepsy Therapeutics Market: Growth Drivers

Active Government Support and Investments to Expedite Market Growth

Governmental initiatives to improve the healthcare sectors and higher investments in R&D is anticipated to expand at a notable growth of Epilepsy Therapeutics market during the forecast period. Rise in the number of approvals by government bodies is providing beneficial for the patients in controlling the seizures. This is projected to fuel the adoption of anticonvulsant and boost the market growth over the upcoming years.

Epilepsy Therapeutics Market: Restraints

Epilepsy Medicine shortage to hamper the market growth

One of the major factors restraining the growth of Epilepsy Therapeutics market during the forecast period is steep rise in medicine shortage. Patients are stockpiling these medicines as there is a shortage of drugs in pharmacies which has raised an alarm in investigating the medicine supply chain globally. This is ultimately affecting the global Epilepsy Therapeutics market as the market becomes less desirable for Epilepsy Therapeutics medications.

Global Epilepsy Therapeutics Market: Segmentation

The global Epilepsy Therapeutics market is segregated based on Product, distribution channel, end-user, and region.

Based on distributional channel, the global Epilepsy Therapeutics market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment is projected to dominate the global market. growing number of hospitals, along with adequate reimbursement policies provided by these settings, are some of the major factors responsible for higher growth of hospital pharmacy over the upcoming years. This is eventually responsible for the adoption of antiepileptic drugs by the hospital pharmacies globally.

Based on product market has been classified into first generation Epilepsy Therapeutic second-generation Epilepsy Therapeutics and third generation Epilepsy Therapeutics. The second-generation epilepsy therapeutics segment is expected to hold a significant share of the global epilepsy therapeutics. This is due to increased penetration in the market and better effectiveness as compared to first generation Epilepsy Therapeutics

Recent Developments

In January 2020, Eisai Co. Announced the launch of FYCOMPA in China for the treatment of partial-onset seizures in patients aged 12 years and older.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

Regional Landscape

North America dominates the global market for Epilepsy Therapeutics during the forecast period. This is majorly due to higher investments in R&D, increasing awareness and availability of advanced Epilepsy Therapeutics drugs in this region. Moreover, improved healthcare facilities are driving the market for Epilepsy Therapeutics in North America during the forecast period.

Asia Pacific is witnessing a significant growth in the global Epilepsy Therapeutics market over the upcoming years. Due government initiatives in the field, Increased awareness and technological advancement in field is fueling the growth of global Epilepsy Therapeutics market.

Competitive Landscape

Some of the main competitors dominating key players functioning in the global Epilepsy Therapeutics market include. BIAL - PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., SanofiSA, Sunovion Pharmaceuticals Inc., UCB SA and Zogenix Inc.

Global Epilepsy Therapeutics market is segmented as follows:

By Types Covered

Anti-Epileptic Drugs
Brain Surgery
Dietary Supplements
Ketogenic Diet
Surgical Therapies

By End Users Covered:

Ambulatory Surgical Centers
Hospitals& Clinics
Home Care Settings
Neurology Centers

By Products Covered:

First Generation Epilepsy Therapeutics
Second Generation Epilepsy Therapeutics
Third Generation Epilepsy Therapeutics

By Distribution Channels Covered:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy-User

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Epilepsy Therapeutics Market, (2022 - 2028) (USD Billion)
- 2.2 Global Epilepsy Therapeutics Market : snapshot
Chapter 3. Global Epilepsy Therapeutics Market - Industry Analysis
- 3.1 Epilepsy Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Active Government Support and Investments to Expedite Market Growth
- 3.3 Market Restraints
  - 3.3.1. Epilepsy Medicine shortage to hamper the market growth
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Types Covered
  - 3.7.2 Market attractiveness analysis By End Users Covered:
  - 3.7.3 Market attractiveness analysis By Products Covered:
  - 3.7.4 Market attractiveness analysis By Distribution Channels Covered:
Chapter 4. Global Epilepsy Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Epilepsy Therapeutics Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Epilepsy Therapeutics Market - Types Covered Analysis
- 5.1 Global Epilepsy Therapeutics Market overview: By Types Covered
  - 5.1.1 Global Epilepsy Therapeutics Market share, By Types Covered, 2021 and 2028
- 5.2 Anti-Epileptic Drugs
  - 5.2.1 Global Epilepsy Therapeutics Market by Anti-Epileptic Drugs, 2022 - 2028 (USD Billion)
- 5.3 Brain Surgery
  - 5.3.1 Global Epilepsy Therapeutics Market by Brain Surgery, 2022 - 2028 (USD Billion)
- 5.4 Dietary Supplements
  - 5.4.1 Global Epilepsy Therapeutics Market by Dietary Supplements, 2022 - 2028 (USD Billion)
- 5.5 Ketogenic Diet
  - 5.5.1 Global Epilepsy Therapeutics Market by Ketogenic Diet, 2022 - 2028 (USD Billion)
- 5.6 Surgical Therapies
  - 5.6.1 Global Epilepsy Therapeutics Market by Surgical Therapies, 2022 - 2028 (USD Billion)
Chapter 6. Global Epilepsy Therapeutics Market - End Users Covered: Analysis
- 6.1 Global Epilepsy Therapeutics Market overview: By End Users Covered:
  - 6.1.1 Global Epilepsy Therapeutics Market share, By End Users Covered:, 2021 and 2028
- 6.2 Ambulatory Surgical Centers
  - 6.2.1 Global Epilepsy Therapeutics Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Billion)
- 6.3 Hospitals& Clinics
  - 6.3.1 Global Epilepsy Therapeutics Market by Hospitals& Clinics, 2022 - 2028 (USD Billion)
- 6.4 Home Care Settings
  - 6.4.1 Global Epilepsy Therapeutics Market by Home Care Settings, 2022 - 2028 (USD Billion)
- 6.5 Neurology Centers
  - 6.5.1 Global Epilepsy Therapeutics Market by Neurology Centers, 2022 - 2028 (USD Billion)
Chapter 7. Global Epilepsy Therapeutics Market - Products Covered: Analysis
- 7.1 Global Epilepsy Therapeutics Market overview: By Products Covered:
  - 7.1.1 Global Epilepsy Therapeutics Market share, By Products Covered:, 2021 and 2028
- 7.2 First Generation Epilepsy Therapeutics
  - 7.2.1 Global Epilepsy Therapeutics Market by First Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
- 7.3 Second Generation Epilepsy Therapeutics
  - 7.3.1 Global Epilepsy Therapeutics Market by Second Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
- 7.4 Third Generation Epilepsy Therapeutics
  - 7.4.1 Global Epilepsy Therapeutics Market by Third Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
Chapter 8. Global Epilepsy Therapeutics Market - Distribution Channels Covered: Analysis
- 8.1 Global Epilepsy Therapeutics Market overview: By Distribution Channels Covered:
  - 8.1.1 Global Epilepsy Therapeutics Market share, By Distribution Channels Covered:, 2021 and 2028
- 8.2 Hospital Pharmacy
  - 8.2.1 Global Epilepsy Therapeutics Market by Hospital Pharmacy, 2022 - 2028 (USD Billion)
- 8.3 Retail Pharmacy
  - 8.3.1 Global Epilepsy Therapeutics Market by Retail Pharmacy, 2022 - 2028 (USD Billion)
- 8.4 Online Pharmacy-User
  - 8.4.1 Global Epilepsy Therapeutics Market by Online Pharmacy-User, 2022 - 2028 (USD Billion)
Chapter 9. Epilepsy Therapeutics Market - Regional Analysis
- 9.1 Global Epilepsy Therapeutics Market Regional Overview
- 9.2 Global Epilepsy Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
- 9.3. North America
  - 9.3.1 North America Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
    - 9.3.1.1 North America Epilepsy Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 9.4 North America Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028
  - 9.4.1 North America Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028 (USD Billion)
- 9.5 North America Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028
  - 9.5.1 North America Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028 (USD Billion)
- 9.6 North America Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028
  - 9.6.1 North America Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028 (USD Billion)
- 9.7 North America Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028
  - 9.7.1 North America Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028 (USD Billion)
- 9.4. Europe
  - 9.4.2 Europe Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
    - 9.4.2.1 Europe Epilepsy Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 9.4 Europe Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028
  - 9.4.1 Europe Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028 (USD Billion)
- 9.5 Europe Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028
  - 9.5.1 Europe Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028 (USD Billion)
- 9.6 Europe Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028
  - 9.6.1 Europe Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028 (USD Billion)
- 9.7 Europe Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028
  - 9.7.1 Europe Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028 (USD Billion)
- 9.5. Asia Pacific
  - 9.5.3 Asia Pacific Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
    - 9.5.3.1 Asia Pacific Epilepsy Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 9.4 Asia Pacific Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028
  - 9.4.1 Asia Pacific Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028 (USD Billion)
- 9.5 Asia Pacific Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028
  - 9.5.1 Asia Pacific Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028 (USD Billion)
- 9.6 Asia Pacific Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028
  - 9.6.1 Asia Pacific Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028 (USD Billion)
- 9.7 Asia Pacific Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028
  - 9.7.1 Asia Pacific Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028 (USD Billion)
- 9.6. Latin America
  - 9.6.4 Latin America Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
    - 9.6.4.1 Latin America Epilepsy Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 9.4 Latin America Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028
  - 9.4.1 Latin America Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028 (USD Billion)
- 9.5 Latin America Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028
  - 9.5.1 Latin America Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028 (USD Billion)
- 9.6 Latin America Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028
  - 9.6.1 Latin America Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028 (USD Billion)
- 9.7 Latin America Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028
  - 9.7.1 Latin America Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028 (USD Billion)
- 9.7. The Middle-East and Africa
  - 9.7.5 The Middle-East and Africa Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
    - 9.7.5.1 The Middle-East and Africa Epilepsy Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
- 9.4 The Middle-East and Africa Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028
  - 9.4.1 The Middle-East and Africa Epilepsy Therapeutics Market, by Types Covered, 2022 - 2028 (USD Billion)
- 9.5 The Middle-East and Africa Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028
  - 9.5.1 The Middle-East and Africa Epilepsy Therapeutics Market, by End Users Covered:, 2022 - 2028 (USD Billion)
- 9.6 The Middle-East and Africa Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028
  - 9.6.1 The Middle-East and Africa Epilepsy Therapeutics Market, by Products Covered:, 2022 - 2028 (USD Billion)
- 9.7 The Middle-East and Africa Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028
  - 9.7.1 The Middle-East and Africa Epilepsy Therapeutics Market, by Distribution Channels Covered:, 2022 - 2028 (USD Billion)
Chapter 10. Company Profiles
- 10.1 BIAL - PORTELA & CA SA
  - 10.1.1 Overview
  - 10.1.2 Financials
  - 10.1.3 Product Portfolio
  - 10.1.4 Business Strategy
  - 10.1.5 Recent Developments
- 10.2 GlaxoSmithKline Plc
  - 10.2.1 Overview
  - 10.2.2 Financials
  - 10.2.3 Product Portfolio
  - 10.2.4 Business Strategy
  - 10.2.5 Recent Developments
- 10.3 Johnson & Johnson Services Inc.
  - 10.3.1 Overview
  - 10.3.2 Financials
  - 10.3.3 Product Portfolio
  - 10.3.4 Business Strategy
  - 10.3.5 Recent Developments
- 10.4 Novartis AG
  - 10.4.1 Overview
  - 10.4.2 Financials
  - 10.4.3 Product Portfolio
  - 10.4.4 Business Strategy
  - 10.4.5 Recent Developments
- 10.5 Pfizer Inc.
  - 10.5.1 Overview
  - 10.5.2 Financials
  - 10.5.3 Product Portfolio
  - 10.5.4 Business Strategy
  - 10.5.5 Recent Developments
- 10.6 SanofiSA
  - 10.6.1 Overview
  - 10.6.2 Financials
  - 10.6.3 Product Portfolio
  - 10.6.4 Business Strategy
  - 10.6.5 Recent Developments
- 10.7 Sunovion Pharmaceuticals Inc.
  - 10.7.1 Overview
  - 10.7.2 Financials
  - 10.7.3 Product Portfolio
  - 10.7.4 Business Strategy
  - 10.7.5 Recent Developments
- 10.8 UCB SA and Zogenix Inc.
  - 10.8.1 Overview
  - 10.8.2 Financials
  - 10.8.3 Product Portfolio
  - 10.8.4 Business Strategy
  - 10.8.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Epilepsy Therapeutics Market attractiveness, By Types Covered
6. Global Epilepsy Therapeutics Market attractiveness, By End Users Covered:
7. Global Epilepsy Therapeutics Market attractiveness, By Products Covered:
8. Global Epilepsy Therapeutics Market attractiveness, By Distribution Channels Covered:
9. Global Epilepsy Therapeutics Market share by Types Covered, 2022 and 2028 (USD Billion)
10. Global Epilepsy Therapeutics Market by Anti-Epileptic Drugs, 2022 - 2028 (USD Billion)
11. Global Epilepsy Therapeutics Market by Brain Surgery, 2022 - 2028 (USD Billion)
12. Global Epilepsy Therapeutics Market by Dietary Supplements, 2022 - 2028 (USD Billion)
13. Global Epilepsy Therapeutics Market by Ketogenic Diet, 2022 - 2028 (USD Billion)
14. Global Epilepsy Therapeutics Market by Surgical Therapies, 2022 - 2028 (USD Billion)
15. Global Epilepsy Therapeutics Market share by End Users Covered:, 2022 and 2028 (USD Billion)
16. Global Epilepsy Therapeutics Market by Ambulatory Surgical Centers, 2022 - 2028 (USD Billion)
17. Global Epilepsy Therapeutics Market by Hospitals& Clinics, 2022 - 2028 (USD Billion)
18. Global Epilepsy Therapeutics Market by Home Care Settings, 2022 - 2028 (USD Billion)
19. Global Epilepsy Therapeutics Market by Neurology Centers, 2022 - 2028 (USD Billion)
20. Global Epilepsy Therapeutics Market share by Products Covered:, 2022 and 2028 (USD Billion)
21. Global Epilepsy Therapeutics Market by First Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
22. Global Epilepsy Therapeutics Market by Second Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
23. Global Epilepsy Therapeutics Market by Third Generation Epilepsy Therapeutics, 2022 - 2028 (USD Billion)
24. Global Epilepsy Therapeutics Market share by Distribution Channels Covered:, 2022 and 2028 (USD Billion)
25. Global Epilepsy Therapeutics Market by Hospital Pharmacy, 2022 - 2028 (USD Billion)
26. Global Epilepsy Therapeutics Market by Retail Pharmacy, 2022 - 2028 (USD Billion)
27. Global Epilepsy Therapeutics Market by Online Pharmacy-User, 2022 - 2028 (USD Billion)
28. Global Epilepsy Therapeutics Market share, by Region, 2022 and 2028
29. North America Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
30. Europe Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
31. Asia Pacific Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
32. Latin America Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)
33. The Middle-East and Africa Epilepsy Therapeutics Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global Epilepsy Therapeutics Market: Snapshot
2. Drivers of the Epilepsy Therapeutics Market: impact analysis
3. North America Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
4. North America Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
5. North America Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
6. North America Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
7. U.S. Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
8. U.S. Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
9. U.S. Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
10. U.S. Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
11. Canada Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
12. Canada Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
13. Canada Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
14. Canada Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
15. Europe Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
16. Europe Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
17. Europe Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
18. Europe Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
19. Germany Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
20. Germany Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
21. Germany Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
22. Germany Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
23. France Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
24. France Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
25. France Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
26. France Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
27. U.K. Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
28. U.K. Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
29. U.K. Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
30. U.K. Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
31. Italy Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
32. Italy Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
33. Italy Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
34. Italy Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
35. Spain Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
36. Spain Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
37. Spain Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
38. Spain Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
39. Rest of Europe Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
40. Rest of Europe Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
41. Rest of Europe Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
42. Rest of Europe Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
43. Asia Pacific Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
44. Asia Pacific Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
45. Asia Pacific Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
46. Asia Pacific Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
47. China Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
48. China Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
49. China Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
50. China Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
51. Japan Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
52. Japan Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
53. Japan Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
54. Japan Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
55. India Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
56. India Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
57. India Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
58. India Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
59. South Korea Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
60. South Korea Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
61. South Korea Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
62. South Korea Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
63. South-East Asia Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
64. South-East Asia Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
65. South-East Asia Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
66. South-East Asia Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
67. Rest of Asia Pacific Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
68. Rest of Asia Pacific Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
69. Rest of Asia Pacific Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
70. Rest of Asia Pacific Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
71. Latin America Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
72. Latin America Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
73. Latin America Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
74. Latin America Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
75. Brazil Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
76. Brazil Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
77. Brazil Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
78. Brazil Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
79. Mexico Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
80. Mexico Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
81. Mexico Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
82. Mexico Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
83. Rest of Latin America Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
84. Rest of Latin America Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
85. Rest of Latin America Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
86. Rest of Latin America Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
87. The Middle-East and Africa Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
88. The Middle-East and Africa Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
89. The Middle-East and Africa Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
90. The Middle-East and Africa Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
91. GCC Countries Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
92. GCC Countries Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
93. GCC Countries Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
94. GCC Countries Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
95. South Africa Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
96. South Africa Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
97. South Africa Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
98. South Africa Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)
99. Rest of Middle-East Africa Epilepsy Therapeutics Market revenue, By Types Covered, 2022 - 2028 (USD Billion)
100. Rest of Middle-East Africa Epilepsy Therapeutics Market revenue, By End Users Covered:, 2022 - 2028 (USD Billion)
101. Rest of Middle-East Africa Epilepsy Therapeutics Market revenue, By Products Covered:, 2022 - 2028 (USD Billion)
102. Rest of Middle-East Africa Epilepsy Therapeutics Market revenue, By Distribution Channels Covered:, 2022 - 2028 (USD Billion)

Methodology

Free Analysis

Epilepsy is a severe neurological disorder with unpredictable seizures. Epilepsy affects millions of people all over the world and it is the one of the most common neurological disorder. Seizures may be classified as generalized seizures, focal seizures, and other seizures. Among these, focal seizures are the most common type of seizures. Generalized seizures comprise tonic seizures, myoclonic seizures, absences, clonic seizures, and atonic seizures. Focal seizures involve complex partial seizures and secondary generalized clonic/tonic seizures (sGCTS). When a group of nerve cells or neurons in the brain send wrong or multiple signals to the body, at that time seizures occur. The growing prevalence of neurological disorders globally is expected to propel the growth of the global market over the coming years. Moreover, increasing awareness about treatment and diagnostics of neurological disorders and easy availability of drugs in the developed market is expected to propel the growth of the market in the near future.

The global epilepsy therapeutics market is segmented as product type, distribution channel, and by geography. Based on product type, the epilepsy therapeutics market is segmented into first-generation epilepsy therapeutics, second-generation epilepsy therapeutics, and third-generation epilepsy therapeutics. On the basis of the distribution channel, the epilepsy therapeutics market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Global Epilepsy Therapeutics Market

North America accounted for the dominant share in the global market for epilepsy therapeutics in 2017 and is anticipated to continue with its regional supremacy over the forthcoming years as well. For epilepsy drugs, North America is the most mature market and hence is expected to grow slowly over the forecast period. The high government support, strong research and development platform, and strong pipeline for epilepsy drugs for the development of next-generation anti-epileptic drugs are the key factors contributing for the high share of North America epilepsy therapeutics market.

Asia Pacific is expected to register the highest CAGR in the global epilepsy therapeutics market in the coming years. The growing awareness about advanced anti-epileptic drug treatment in emerging economies is expected to boost the growth of Asia Pacific epilepsy therapeutics market over the forecast period.

Some of the key players in the epilepsy therapeutics market are Eisai Co., Ltd., GlaxoSmithKline, Pfizer Inc., UCB S.A., Sumitomo Dainippon Pharma Co., Ltd., Janssen Pharmaceutical, Abbott, Novartis AG, and Shire. The growing prevalence of epilepsy and increasing competition among the key players in the market for the development of advanced drugs is expected to propel the growth of the market over the coming years.

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

RelatedNews

FrequentlyAsked Questions

Which key factors will influence Epilepsy Therapeutics market growth over 2022-2028?

Innovation of new treatment products with better efficiency is expected to drive the market growth. Rising number of mergers and acquisitions, new product launches, and increasing number of collaborations and partnerships are some of the latest trends that have been observed in the global epilepsy therapeutics market.

What will be the value of the Epilepsy Therapeutics market during 2022-2028?

According to the Zion Market Research report, the global Epilepsy Therapeutics market was worth around USD 10.10 billion in 2021 and is estimated to grow to about USD 12.13 billion by 2028, with a compound annual growth rate (CAGR) of approximately 3.10 percent over the forecast period.

Which region will contribute notably towards the Epilepsy Therapeutics market value?

North America is expected to dominate and account for a prominent share of the global epilepsy market during the forecast period due to. High awareness among patient population towards new treatment and higher availability of R & D. During the forecast period, the global market is predicted to rise at a rapid pace, with Asia leading the way, followed by Europe. India and China are predicted to be the Asia Pacific region's fastest-expanding epilepsy therapeutics markets.

Which are the major players leveraging the Epilepsy Therapeutics market growth?

Some of the main competitors dominating key players functioning in the global Epilepsy Therapeutics market include BIAL - PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sunovion Pharmaceuticals Inc., UCB SA and Zogenix Inc.